CRYO-CELL INTL INC (CCEL) Stock Price, Quote, News and Overview
NYSEARCA:CCEL - NYSE Arca - US2288951088 - Common Stock - Currency: USD
CCEL Quote, Performance and Key Statistics
NYSEARCA:CCEL (3/7/2025, 8:10:30 PM)
7.1726
+0.14 (+2.03%)
The current stock price of CCEL is 7.1726 USD. In the past month the price decreased by -9.66%. In the past year, price increased by 18.56%.
CCEL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11.74 | 87.86B | ||
| CVS | CVS HEALTH CORP | 12.24 | 83.63B | ||
| LH | LABCORP HOLDINGS INC | 17.37 | 21.18B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.46 | 19.48B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 15.78 | 14.07B | ||
| DVA | DAVITA INC | 15.48 | 11.76B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 115.35 | 11.05B | ||
| CHE | CHEMED CORP | 25.75 | 8.72B | ||
| HIMS | HIMS & HERS HEALTH INC | 66.57 | 7.99B | ||
| OPCH | OPTION CARE HEALTH INC | 27.88 | 5.62B | ||
| CRVL | CORVEL CORP | 26.02 | 5.59B | ||
| GH | GUARDANT HEALTH INC | N/A | 4.85B |
Related stock screener links
About CCEL
Company Profile
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Company Info
CRYO-CELL INTL INC
700 Brooker Creek Blvd, Suite 1800
Oldsmar FLORIDA US
CEO: David Portnoy
Employees: 82
Company Website: https://www.cryo-cell.com/
Investor Relations: http://www.cryo-cell.com/investor-relations
Phone: 18137492104
CRYO-CELL INTL INC / CCEL FAQ
What is the stock price of CRYO-CELL INTL INC today?
The current stock price of CCEL is 7.1726 USD. The price increased by 2.03% in the last trading session.
What is the ticker symbol for CRYO-CELL INTL INC stock?
The exchange symbol of CRYO-CELL INTL INC is CCEL and it is listed on the NYSE Arca exchange.
On which exchange is CCEL stock listed?
CCEL stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for CRYO-CELL INTL INC stock?
7 analysts have analysed CCEL and the average price target is 9.18 USD. This implies a price increase of 27.99% is expected in the next year compared to the current price of 7.1726. Check the CRYO-CELL INTL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CRYO-CELL INTL INC worth?
CRYO-CELL INTL INC (CCEL) has a market capitalization of 57.95M USD. This makes CCEL a Micro Cap stock.
How many employees does CRYO-CELL INTL INC have?
CRYO-CELL INTL INC (CCEL) currently has 82 employees.
What are the support and resistance levels for CRYO-CELL INTL INC (CCEL) stock?
CRYO-CELL INTL INC (CCEL) has a support level at 7.09 and a resistance level at 7.57. Check the full technical report for a detailed analysis of CCEL support and resistance levels.
Is CRYO-CELL INTL INC (CCEL) expected to grow?
The Revenue of CRYO-CELL INTL INC (CCEL) is expected to grow by 2.15% in the next year. Check the estimates tab for more information on the CCEL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CRYO-CELL INTL INC (CCEL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CCEL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CCEL, evaluating the profitability, health, valuation and growth aspects
- CRYO-CELL INTL INC (CCEL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CRYO-CELL INTL INC (CCEL) Sales and EPS estimates to see what analysts future expectations are.
- CRYO-CELL INTL INC (CCEL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CRYO-CELL INTL INC (CCEL) Insider and Institutional Ownership to learn about the owners and their transactions.
- CRYO-CELL INTL INC (CCEL) Stock Chart to make your own analysis
- CRYO-CELL INTL INC (CCEL) Latest news and press-releases to stay up to date.
Does CRYO-CELL INTL INC (CCEL) stock pay dividends?
CRYO-CELL INTL INC (CCEL) has a dividend yield of 14.22%. The yearly dividend amount is currently 0.9. Check the full fundamental report for a detailed analysis of CCEL dividend history, reliability and sustainability.
When does CRYO-CELL INTL INC (CCEL) report earnings?
CRYO-CELL INTL INC (CCEL) will report earnings on 2025-04-14, after the market close.
What is the Price/Earnings (PE) ratio of CRYO-CELL INTL INC (CCEL)?
CRYO-CELL INTL INC (CCEL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).
What is the Short Interest ratio of CRYO-CELL INTL INC (CCEL) stock?
The outstanding short interest for CRYO-CELL INTL INC (CCEL) is 0.41% of its float. Check the ownership tab for more information on the CCEL short interest.
CCEL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CCEL. When comparing the yearly performance of all stocks, CCEL turns out to be only a medium performer in the overall market: it outperformed 54.85% of all stocks.
CCEL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CCEL. There are concerns on the financial health of CCEL while its profitability can be described as average.
CCEL Financial Highlights
Over the last trailing twelve months CCEL reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS decreased by -453.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CCEL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to CCEL. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 125.95% and a revenue growth 2.15% for CCEL